[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Brezar et al., 2011 - Google Patents

Beyond the hormone: insulin as an autoimmune target in type 1 diabetes

Brezar et al., 2011

View PDF
Document ID
1535168624823918148
Author
Brezar V
Carel J
Boitard C
Mallone R
Publication year
Publication venue
Endocrine reviews

External Links

Snippet

Insulin is not only the hormone produced by pancreatic β-cells but also a key target antigen of the autoimmune islet destruction leading to type 1 diabetes. Despite cultural biases between the fields of endocrinology and immunology, these two facets should not be …
Continue reading at academic.oup.com (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens

Similar Documents

Publication Publication Date Title
Brezar et al. Beyond the hormone: insulin as an autoimmune target in type 1 diabetes
Morran et al. Immunogenetics of type 1 diabetes mellitus
Pugliese Autoreactive T cells in type 1 diabetes
Herold et al. Type 1 diabetes: translating mechanistic observations into effective clinical outcomes
Miyadera et al. Cell-surface MHC density profiling reveals instability of autoimmunity-associated HLA
Gianani et al. The stages of type 1A diabetes: 2005
Graham et al. Pathogenic mechanisms in type 1 diabetes: the islet is both target and driver of disease
Krishnamurthy et al. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP
Culina et al. Mechanisms in endocrinology: insulin and type 1 diabetes: immune connections
CN101646781B (en) Autoimmune disease diagnose and treat target and application thereof
Unanue Antigen presentation in the autoimmune diabetes of the NOD mouse
Boitard Pancreatic islet autoimmunity
Viret et al. Thymus-specific serine protease controls autoreactive CD4 T cell development and autoimmune diabetes in mice
JP2013538555A (en) An isolated high affinity entity with T cell receptor-like specificity for a natural complex of MHC class II and glutamate decarboxylase (GAD) autoantigenic peptide
JPH06510903A (en) Diagnosis and treatment of autoimmune diseases
JP2013535963A (en) An isolated high affinity entity with T cell receptor-like specificity for a natural complex of MHC class II and a diabetes-related autoantigenic peptide
Meagher et al. Spontaneous development of a pancreatic exocrine disease in CD28-deficient NOD mice
Uibo et al. GAD65 autoimmunity—clinical studies
Tsui et al. Targeting of pancreatic glia in type 1 diabetes
La Torre et al. Immunology of β-cell destruction
Mannering et al. Insulin’s other life: an autoantigen in type 1 diabetes
Kanatsuna et al. Etiopathogenesis of insulin autoimmunity
Pearson et al. Proinsulin expression shapes the TCR repertoire but fails to control the development of low-avidity insulin-reactive CD8+ T cells
WO2016131911A1 (en) Methods for the treatment and diagnosis of type 1 diabetes
Houeiss et al. Preclinical models to evaluate the human response to autoantigen and antigen-specific immunotherapy in human type 1 diabetes